This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Lek Pharmaceuticals D.d.. Active years: 2016.
Company Filing History:
Years Active: 2016
Title: The Innovations of Janez Kosmrlj
Introduction
Janez Kosmrlj is a notable inventor based in Ljubljana, Slovenia. He has made significant contributions to the field of organic chemistry, particularly in the synthesis of pharmaceutical compounds. His work has led to advancements in the development of important medications.
Latest Patents
Janez Kosmrlj holds a patent for "Key intermediates for the synthesis of rosuvastatin or pharmaceutically acceptable salts thereof." This invention focuses on the preparation of key intermediates, including N-(4-(4-fluorophenyl)-6-isopropyl-5-methylpyrimidin-2-yl)-N-methylmethanesulfonamide, N-(4-(4-fluorophenyl)-5-(bromomethyl)-6-isopropylpyrimidin-2-yl)-N-methylmethanesulfonamide, and N-(4-(4-fluorophenyl)-5-(hydroxymethyl)-6-isopropylpyrimidin-2-yl)-N-methylmethanesulfonamide. These compounds are essential in the preparation of Rosuvastatin, a medication used to lower cholesterol levels.
Career Highlights
Janez Kosmrlj is currently employed at Lek Pharmaceuticals D.d., a leading pharmaceutical company in Slovenia. His expertise in organic chemistry has been instrumental in the development of innovative pharmaceutical solutions. He has dedicated his career to advancing medical science through his research and inventions.
Collaborations
One of his notable collaborators is Zdenko Casar. Together, they have worked on various projects that have contributed to the field of pharmaceuticals.
Conclusion
Janez Kosmrlj's contributions to organic chemistry and his patent for key intermediates in the synthesis of Rosuvastatin highlight his importance as an inventor. His work continues to impact the pharmaceutical industry positively.